Drug Trial Radar · NCT04123444
Infusion of Prostacyclin (Iloprost) vs Placebo for 72-hours in Patients With Septic Shock Suffering From Organ Failure
Last checked: Nov 20, 2026Latest source record: May 7, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
279
Actual
Start
Oct 30, 2019
Primary completion
Jun 28, 2022
Study completion Jun 28, 2022
Sponsor
- Lead sponsor
- Jakob Stensballe, MD, PhDAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Innovation Fund Denmark; Independent Research Fund Denmark
- First posted
- Oct 11, 2019
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this trial is to investigate the efficacy and safety of continuous intravenous administration of low dose iloprost versus placebo for 72-hours, in up to a total of 380 patients with septic shock suffering from organ failure. The study hypothesis is that iloprost may be beneficial as an endothelial rescue treatment as it is anticipated to deactivate the endothelium and restore vascular integrity in septic shock patients suffering from organ failure caused by endothelial breakdown, ultimately improving survival.
Conditions
- Septic Shock
Interventions
IloprostDrug
Continuously infusion for 72 hours. treatment dose 1 ng/kg/min
Isotonic salineDrug
Continuously infusion for 72 hours.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Modified Sequential Organ Failure Assessment (SOFA)Time frame: Up to 90 days after randomization
Locations
6 sites in 1 country. Site status is shown where the registry gives one.
Dept. of Anaesthesia and Intensive Care, Bispebjerg Hospital
Copenhagen, Denmark
Dept. of Intensive Care, Copenhagen University Hospital, Rigshospitalet
Copenhagen, Denmark
Dept. of Intensive Care, Copenhagen University Hospital Herlev
Herlev, Denmark
Dept. of Anaesthesia and Intensive Care, Nordsjaelands Hospital
Hillerød, Denmark
Dept. of Anaesthesia and Intensive Care, Hvidovre Hospital
Hvidovre, Denmark
Region Sealand University Hospital
Køge, Denmark
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.